Sex differences in pain-related behaviors and clinical progression of disease in mouse models of colonic pain
Sign Up to like & getrecommendations! Published in 2022 at "Pain"
DOI: 10.1097/j.pain.0000000000002683
Abstract: Supplemental Digital Content is Available in the Text. Preclinical experiments in mouse models of visceral pain show marked sex differences in hypersensitivity, behavioral manifestation of pain-related responses, and clinical progression of disease. read more here.
Keywords: clinical progression; pain related; progression disease; mouse models ... See more keywords
Abstract 3154: Outcomes after progression of disease with anti-PD-1/PDL1 therapy for advanced melanoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-3154
Abstract: Purpose:Antibodies blocking programmed death-1 receptor (anti-PD-1) produce durable responses in patients with metastatic melanoma, although >50% of patients ultimately experience disease progression. We aimed to identify prognostic factors and outcomes to subsequent therapies in patients… read more here.
Keywords: advanced melanoma; disease; progression disease; outcomes progression ... See more keywords
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.18.02365
Abstract: PURPOSE Understanding the immunobiology of the 15% to 30% of patients with follicular lymphoma (FL) who experience progression of disease within 24 months (POD24) remains a priority. Solid tumors with low levels of intratumoral immune… read more here.
Keywords: immune infiltration; progression disease; follicular lymphoma; infiltration ... See more keywords
Nomograms to predict progression of disease within 24 months in patients with localized natural killer/T-cell lymphoma.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0307
Abstract: Aims: Progression of disease within 24 months (POD24) is associated with poor survival in some subtypes of lymphoma.The aim is to identify high-risk patients with localized extranodal natural killer/T-cell lymphoma (ENKTL) and to define clinical factors… read more here.
Keywords: oncology; pod24; within months; progression disease ... See more keywords